California Cannabis Testing Highlights the Importance of Quality Control and Safe Processes
August 14th, 2018
Exclusive, News, Top News
According to statistics provided by California’s Bureau of Cannabis Control, 20% of all cannabis products analyzed by August 6, 2108 received a failed certificate of analysis. The most common reason was inaccurate labeling, for instance misrepresenting the percentage of CBD in a product. Together, the presence of disallowed pesticides, solvents, and microbials account for 30% of the failed certificates. Clearly, cultivators and manufacturers are having a difficult time creating safe and trusted products for the world’s largest legal cannabis market, and the problems are not limited to California. Similar situations have occurred in Canada with Licensed Producers.
Rubicon Organics™ is intent on demonstrating that certified organic products, properly tested and labeled, can lead the way toward creating consumer confidence in the nascent legal cannabis industry. As cannabis cultivation comes out of the basements and closets into the fully regulated light of day, Rubicon believes that adhering to the most strict quality and health standards is essential to building brands that consumers can trust with their well-being.
Smaller sample studies from earlier in 2018 present even more alarming statistics than those noted above. Steep Hill Labs collected samples from 15 dispensaries in Southern California and found 93% of samples tested positive for pesticides. Then Steep Hill followed up with a study pointing to the cloning process, and the growth media used to promote root growth, as possible culprits for the widespread positive tests.
With the scientific understanding of cannabis just now advancing due to relaxed regulations, following years of restrictions, it is more clear what is not known with certainty than what is. Agricultural technology research is turning its focus to cannabis, and ultimately cultivators will benefit from genetic selection and research-driven advancements such as safe, cannabis-specific pesticides. For now, many growers are going with what they know, and when faced with widespread crop loss may bend the new rules some to protect their investment.
The Rubicon Organics™ Solution
The founders of Rubicon Organics were in on the ground floor of the world’s first certified organic producer, Whistler Medical Marijuana Corporation. After leaving that successful venture, Rubicon’s CEO and CSO started experimenting with organic greenhouse cultivation. From improving on the classic Dutch Venlo greenhouse design, to creating their own proprietary soil mixes and growth media, the two perfected the art and the science of growing certified organic cannabis using greenhouse technology.
The result is Rubicon Organics™, on the verge of becoming Canada’s third certified organic licensed producer. Its 125,000 square foot Delta, BC greenhouse facility is in the detailed review stage of the ACMPR permitting process. The company also owns a 40,000 sf state-of-the art and custom designed greenhouse in Washington state that is currently leased to a licensed producer there, and has an off-take agreement with a 120,000 sf outdoor operation in California. Rubicon owns two brands of cannabis products, with the 1964 Supply Co.™ brand distributed in California and the Doctor & Crook Co.™ brand distributed in Washington through a state-licensed processor.
Video of Rubicon Organics’ Delta BC facility.
Cultivating large amounts of consistent, high quality cannabis at a low cost is a difficult proposition. Rubicon believes it can produce such crops, certified organic, at a cost of $.50/gram once facilities are running at full production levels. The certified organic distinction allows the company to charge a premium for its products, translating to healthier margins than non-organic producers operating with similar production costs.
In seeking to build a family of cannabis products that consumers can trust implicitly, Rubicon is betting on organics as a seal of quality, health, and safety. Consumer trends toward organic products reinforce the soundness of the strategy, as does the current lack of certified organic cannabis. Utilizing the company’s own proprietary growing supplies and system, based on years of research and experimentation, should allow Rubicon to limit the variables and inputs that can create uncertainty in the growing environment. Stay tuned, as Rubicon Organics™ plans on going public soon and anticipates plenty of major developments in the coming months.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.